Phillips-Medisize is first Green Tier facility in Hudson
The Phillips-Medisize Design Development Center in Hudson has reached the level of environmental stewardship needed for entrance into the Wisconsin Department of Natural Resource’s Green Tier program.
The accomplishment was celebrated Thursday morning, Oct. 10, with a program in front of the facility at 1201 Hanley Road. DNR Secretary Cathy Stepp was the featured speaker.
“When I look at folks like the Phillips-Medisize team, I am reminded that there are people and stars out there that other companies can aspire to,” said Stepp, who later toured the plant where a variety of medical device and diagnostic products are designed, developed and manufactured.
Under the Green Tier program, companies voluntarily commit to environmental performance standards that go beyond regulatory compliance. In return, they are freed from some of the reporting required of other companies.
Phillips-Medisize has worked with the DNR to achieve specific waste and energy reduction goals, and has implemented recycling and technological innovations to protect the environment.
Stepp said the company demonstrates a message the DNR preaches.
“You can actually create jobs and have economic development, and at the same time not just protect the environment, but even enhance the environmental conditions around us,” she said.
Matt Jennings, president and CEO of Phillips-Medisize, agreed with Stepp.
“It helps us not only in being more environmentally friendly, but in driving a better bottom line -- a better green line,” Jennings said of the program. “It enables us to run leaner, run cleaner and run more efficiently.”
The facility is the first in Hudson to achieve Green Tier 1 status, but the last of Phillips-Medisize’s 12 Wisconsin facilities to join the program. The Hudson facility is also the company’s headquarters.
Jennings noted that the company has undergone tremendous growth in the past three years. In 2011, it had total revenue of just over $200 million. This year, revenue has grown to more than $500 million globally.
The company has expanded to Europe, where it has five facilities, and more recently, to Mexico and China.
But that doesn’t mean jobs are being exported, Jennings indicated.
“The way we play the game is through better design and automation,” he said. “A lot of what we are doing in the case of China will be China for China. It won’t be for export. It’s Europe for Europe.”
In fact, the company is moving production back to the United States as it finds ways to “do things more effectively and efficiently,” Jennings said.
He said about 350 jobs have been added at Phillips-Medisize’s Wisconsin facilities this year. The Hudson Design Development Center employs 115 people. The company has 1,300 employees in Wisconsin and more than 3,100 worldwide.
During the tour of the facility, Jennings told Stepp that many of Phillips-Medisize’s corporate customers are also committed to environmental stewardship and want to partner with companies that have the same commitment. He said customers view it as a discipline that also indicates a commitment to producing quality products.
Vince Hull, manager of the Hudson facility, told the dignitaries, business partners and employees gathered for the occasion that Green Tier is a great methodology for recognizing organizations committed to the environment.
“I’m proud to be a member of a facility that participates in that,” Hull said. “It’s a culture. It’s a way of life that we’ve embraced here at the DDC (Design Development Center).”
Jill Jarchow, who oversees the program at the Hudson facility, said the commitment starts with the top management and extends to every person in the company.
“It is exciting to be the first Green Tier participant in the city of Hudson and we hope that we can help other businesses to achieve that status,” Jarchow said.
Phillips-Medisize is a leading global outsource provider of design and manufacturing services to the medical device and diagnostics, drug delivery and commercial markets, according to a company news release.
More than 75 percent of its revenue comes from the production of medical products such as disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single-use surgical devices and consumable diagnostic components.